FFCP PHASE1:Mm9::chr15:39157363..39157367,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |EntrezGene=NA | ||
|HGNC= | |HGNC= | ||
|MCL_coexpression_id=6 | |MCL_coexpression_id=6 | ||
|TSSclassifier=NA | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |association_with_transcript=NA | ||
|cluster_id=chr15:39157363..39157367,- | |||
|description=CAGE_peak_at_chr15:39157363..39157367,- | |description=CAGE_peak_at_chr15:39157363..39157367,- | ||
|id=chr15:39157363..39157367,- | |id=chr15:39157363..39157367,- | ||
|ontology_enrichment_celltype=CL:0000355!1.01e-11!9 | |ontology_enrichment_celltype=CL:0000355!1.01e-11!9 | ||
|ontology_enrichment_celltype_v019_2=CL:0000355,2.95e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!1.31e-33!3;DOID:4045!1.31e-33!3;DOID:0050686!3.20e-17!6 | |ontology_enrichment_disease=DOID:0060100!1.31e-33!3;DOID:4045!1.31e-33!3;DOID:0050686!3.20e-17!6 | ||
|ontology_enrichment_disease_v019_2=DOID:0060100,6.41e-44,3;DOID:4045,6.41e-44,3;DOID:0050686,1.89e-22,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!1.01e-11!9;UBERON:0002036!1.01e-11!9;UBERON:0002385!1.01e-11!9;UBERON:0000486!1.01e-11!9;UBERON:0001015!1.01e-11!9;UBERON:0004290!1.01e-11!9;UBERON:0003082!1.01e-11!9;UBERON:0000383!1.29e-10!10;UBERON:0002329!1.04e-09!11;UBERON:0003077!1.04e-09!11;UBERON:0003059!1.04e-09!11;UBERON:0007282!1.04e-09!11;UBERON:0009618!1.04e-09!11;UBERON:0007285!1.04e-09!11 | |ontology_enrichment_uberon=UBERON:0001134!1.01e-11!9;UBERON:0002036!1.01e-11!9;UBERON:0002385!1.01e-11!9;UBERON:0000486!1.01e-11!9;UBERON:0001015!1.01e-11!9;UBERON:0004290!1.01e-11!9;UBERON:0003082!1.01e-11!9;UBERON:0000383!1.29e-10!10;UBERON:0002329!1.04e-09!11;UBERON:0003077!1.04e-09!11;UBERON:0003059!1.04e-09!11;UBERON:0007282!1.04e-09!11;UBERON:0009618!1.04e-09!11;UBERON:0007285!1.04e-09!11 | ||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,2.95e-15,9;UBERON:0002036,2.95e-15,9;UBERON:0002385,2.95e-15,9;UBERON:0000486,2.95e-15,9;UBERON:0007503,2.95e-15,9;UBERON:0001015,2.95e-15,9;UBERON:0002329,2.95e-15,9;UBERON:0003082,2.95e-15,9;UBERON:0003059,2.95e-15,9;UBERON:0007282,2.95e-15,9;UBERON:0004290,2.95e-15,9;UBERON:0009618,2.95e-15,9;UBERON:0000383,8.21e-14,10;UBERON:0007524,1.25e-12,11;UBERON:0003077,1.25e-12,11;UBERON:0007285,1.25e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.4409111995798,3.906676722619,3.66466620781659,27.0586484494267,2.04913645487534,4.36959317728038,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.287696137450811,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238436189947321,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.4409111995798,3.906676722619,3.66466620781659,27.0586484494267,2.04913645487534,4.36959317728038,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.287696137450811,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238436189947321,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr15:39157363..39157367,- | |short_description=p@chr15:39157363..39157367,- | ||
}} | }} |
Latest revision as of 05:51, 5 August 2015
Short description: | p@chr15:39157363..39157367, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr15:39157363..39157367, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 2.95e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 2.95e-15 | 9 |
striated muscle tissue | 2.95e-15 | 9 |
muscle tissue | 2.95e-15 | 9 |
multilaminar epithelium | 2.95e-15 | 9 |
epithelial vesicle | 2.95e-15 | 9 |
musculature | 2.95e-15 | 9 |
somite | 2.95e-15 | 9 |
myotome | 2.95e-15 | 9 |
presomitic mesoderm | 2.95e-15 | 9 |
presumptive segmental plate | 2.95e-15 | 9 |
dermomyotome | 2.95e-15 | 9 |
trunk paraxial mesoderm | 2.95e-15 | 9 |
musculature of body | 8.21e-14 | 10 |
dense mesenchyme tissue | 1.25e-12 | 11 |
paraxial mesoderm | 1.25e-12 | 11 |
presumptive paraxial mesoderm | 1.25e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 6.41e-44 | 3 |
muscle cancer | 6.41e-44 | 3 |
organ system cancer | 1.89e-22 | 6 |